Inozyme Pharma Inc. (INZY)
NASDAQ: INZY
· Real-Time Price · USD
4.00
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM
Inozyme Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 333K | 664K | 988K | 988K | 954K | 908K | 865K | 1.15M | 1.01M | 896K | 773K | 492K | 325K | 158K |
Gross Profit | n/a | n/a | n/a | -333K | -664K | -988K | -988K | -954K | -908K | -865K | -1.15M | -1.01M | -896K | -773K | -492K | -325K | -158K |
Operating Income | -107.38M | -104.03M | -99.67M | -92.89M | -81.62M | -75.64M | -72.37M | -71.21M | -70.2M | -68.67M | -67.9M | -65.25M | -62.51M | -56.65M | -49.16M | -63.21M | -60.11M |
Interest Income | 6.41M | 7.67M | 10.77M | 10.4M | 9.98M | 8.94M | 5.17M | 4.49M | 3.2M | 1.93M | 1.16M | 471K | 208K | 211K | 232K | 249K | 262K |
Pretax Income | -106.72M | -102.02M | -96.49M | -88.56M | -77.11M | -71.17M | -68.17M | -67.9M | -67.58M | -67.06M | -67.27M | -65.18M | -62.46M | -56.62M | -48.99M | -62.8M | -59.74M |
Net Income | -106.72M | -102.02M | -96.49M | -88.56M | -77.11M | -70M | -67M | -66.19M | -65.55M | -66.25M | -66.45M | -64.9M | -62.5M | -56.62M | -48.99M | -62.8M | -59.74M |
Selling & General & Admin | 20.98M | 20.8M | 20.93M | 20.7M | 19.52M | 20.8M | 21.67M | 21.66M | 22.31M | 20.83M | 20.34M | 20.53M | 19.58M | 18.93M | 17.95M | 16.18M | 13.42M |
Research & Development | 84.5M | 83.23M | 78.74M | 72.19M | 62.1M | 54.85M | 50.7M | 49.55M | 47.89M | 47.85M | 47.56M | 44.72M | 42.93M | 37.72M | 31.2M | 47.03M | 46.69M |
Other Expenses | 1.9M | n/a | n/a | 20K | -8K | -42K | -42K | -259K | -422K | -493K | -533K | -401K | -153K | -189K | -60K | 162K | 109K |
Operating Expenses | 107.38M | 104.03M | 99.67M | 92.89M | 81.62M | 75.64M | 72.37M | 71.21M | 70.2M | 68.67M | 67.9M | 65.25M | 62.51M | 56.65M | 49.16M | 63.21M | 60.11M |
Interest Expense | 5.64M | 5.56M | 7.47M | 6.05M | 5.43M | 4.43M | 1.1M | 1.1M | 328K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 107.38M | 104.03M | 99.67M | 92.89M | 81.62M | 75.64M | 72.37M | 71.21M | 70.2M | 68.67M | 67.9M | 65.25M | 62.51M | 56.65M | 49.16M | 63.21M | 60.11M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -1.17M | -1.17M | -1.71M | -2.03M | -816K | -819K | -326K | -63K | -171K | -232K | -249K | -262K |
Shares Outstanding (Basic) | 64.28M | 62.81M | 63.28M | 61.94M | 61.77M | 61.77M | 56.76M | 44.86M | 43.72M | 40.71M | 43.66M | 39.7M | 23.69M | 23.64M | 23.64M | 23.49M | 23.43M |
Shares Outstanding (Diluted) | 64.28M | 62.81M | 63.28M | 61.94M | 61.77M | 61.77M | 56.76M | 44.86M | 43.72M | 40.71M | 43.66M | 39.7M | 23.69M | 23.64M | 23.64M | 23.49M | 23.43M |
EPS (Basic) | -1.7 | -1.64 | -1.56 | -1.46 | -1.37 | -1.36 | -1.47 | -1.54 | -1.57 | -1.91 | -2.24 | -2.48 | -2.63 | -2.39 | -2.21 | -3.16 | -3.1 |
EPS (Diluted) | -1.7 | -1.64 | -1.56 | -1.46 | -1.37 | -1.36 | -1.47 | -1.54 | -1.57 | -1.91 | -2.24 | -2.48 | -2.63 | -2.39 | -2.21 | -3.16 | -3.1 |
EBITDA | -100.34M | -95.72M | -88.15M | -81.5M | -71.3M | -66.22M | -67.65M | -68.07M | -68.03M | -67.93M | -67.17M | -64.54M | -61.82M | -55.97M | -48.55M | -62.72M | -59.76M |
EBIT | -101.08M | -96.47M | -89.03M | -82.51M | -72.45M | -67.51M | -68.83M | -69.1M | -68.91M | -68.67M | -67.9M | -65.25M | -62.51M | -56.65M | -49.16M | -63.21M | -60.11M |
Depreciation & Amortization | 736K | 742K | 871K | 1.01M | 1.15M | 1.29M | 1.19M | 1.15M | 1.11M | 1.06M | 1.15M | 1.01M | 896K | 773K | 615K | 491K | 350K |